Skip to main content
. Author manuscript; available in PMC: 2023 Apr 26.
Published in final edited form as: J Alzheimers Dis. 2020;75(4):1391–1403. doi: 10.3233/JAD-191265

Table 3.

Summary of results

Domain Measure Tolcapone effect
size versus placebo
Predicted COMT
genotype effect
Clinical CGI 0.35 (small to medium sized) Yes
Cognitive out of scanner RBANS 0.22 (small) No
Behavioral NPI 0.25 (small) Yes
Cognitive (in scanner) N-back

CGI, Clinical Global Impressions scale; RBANS, Repeatable Battery for the Assessment of Neuropsychological Status; NPI, Neuropsychiatric Inventory-Questionnaire; COMT, catechol-o-methyltransferase.